Skip to main content
Premium Trial:

Request an Annual Quote

Biotage (Once Pyrosequencing) Expects Strong Q4 Revenue Growth

NEW YORK, Feb. 19 (GenomeWeb News) - Biotage, which changed its name from Pyrosequencing late last year, said it expects fourth-quarter 2003 sales to have increased and net loss to have narrowed.

 

Total receipts for the three-month period ended Dec. 31 jumped to SEK105 million ($14.5 million) from SEK34 million one year ago, the company said in an interim fourth-quarter earnings report.

 

The report, which was not comprehensive, also said net loss would decrease to SEK 31 million from SEK44 million in the same period one year ago.

 

The new company was created when Pyrosequencing bought US-based Biotage in October 2003 for around $30 million.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.